SeungSuh (Stanley) Hong
Senior Advisor, Celltrion Healthcare Co. Ltd
Meet SeungSuh (Stanley) Hong
Stanley joined Celltrion in 2002 and was involved in the development of Remsima, the first biosimilar monoclonal antibody to be approved by the European Medicines Agency. He was President and CEO of Celltrion until December 2015.